hero section gradient
9 handpicked stocks

Small Cap Index: Could Africa Growth Unlock Value?

Africa's expanding economies are powered by a new generation of growing companies and rising consumer demand. This basket offers exposure through global companies that provide market access, financial tools, and essential services fueling this growth.

Author avatar

Han Tan | Market Analyst

Published on September 22

Your Basket's Financial Footprint

Market capitalisation breakdown for the provided small cap-focused basket.

Key Takeaways for Investors:
  • Large‑cap dominance generally implies lower volatility and a tendency to track the broader market, reducing idiosyncratic risk.
  • Best used as a core holding within a diversified portfolio, not as a speculative small‑cap growth allocation.
  • Likely to deliver steadier, long‑term value appreciation rather than rapid, short‑term explosive gains.
Total Market Cap
  • V: $668.94B

  • MA: $517.12B

  • MSCI: $41.81B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Africa's economic expansion is driven by dynamic small and mid-sized enterprises, but direct investment can be complex. This group focuses on global 'enabler' companies that build the foundational infrastructure powering this growth, from index providers to payment systems and logistics networks.

2

What You Need to Know

This is an indirect approach to African growth exposure through established US and EU-listed companies. It offers diversified access whilst mitigating some direct risks associated with single emerging market stocks, making it suitable for those exploring small cap opportunities.

3

Why These Stocks

These companies were handpicked as the essential infrastructure providers for African growth. They include major index creators like MSCI and S&P Global, fintech leaders expanding digital payments, and logistics giants facilitating commerce across the continent.

Why You'll Want to Watch These Stocks

🌍

Continental Growth Story

Africa's expanding economies are creating massive opportunities for the companies building essential infrastructure. These enabler firms are positioned at the heart of this transformation.

🚀

Smart Indirect Exposure

Get exposure to African growth through established global companies rather than direct emerging market risks. It's a clever way to tap into the continent's potential with added stability.

💡

Infrastructure Boom

From digital payments to logistics networks, these companies are building the foundational systems that power Africa's entrepreneurial revolution. Early positioning could be rewarding.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Railroad Investment: Beyond the $85 Billion Merger

Railroad Investment: Beyond the $85 Billion Merger

Union Pacific and Norfolk Southern are seeking to merge, creating America's first transcontinental railroad. This landmark consolidation could drive significant investment into rail infrastructure and technology, creating opportunities for companies that support and equip the freight rail industry.

Oracle TikTok Deal May Boost Stocks in 2025

Oracle TikTok Deal May Boost Stocks in 2025

TikTok has finalized the sale of its U.S. operations to an investor group including Oracle, resolving national security concerns and securing its future in the American market. This development creates opportunities for companies in the digital advertising, social commerce, and creator economy sectors that can now capitalize on the platform's stabilized presence and massive user base.

Pharma Reshoring Explained | Manufacturing Investment

Pharma Reshoring Explained | Manufacturing Investment

Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.

Frequently Asked Questions